CELYAD ONCOLOGY SA Financial Liabilities At Fair Value
CELYAD ONCOLOGY SA had Financial Liabilities At Fair Value of EUR 13.55 million as of 2022-06-30, per its 6-K filed 2022-08-05.
Discontinued › Notes
ifrs-full:FinancialLiabilitiesAtFairValue · last filed 2023-03-23
- 2022-06-30: Financial Liabilities At Fair Value 13.55M EUR.
- 2021-12-31: Financial Liabilities At Fair Value 14.68M EUR.
- 2021-06-30: Financial Liabilities At Fair Value 17.49M EUR.
- 2020-12-31: Financial Liabilities At Fair Value 14.68M EUR; Financial Liabilities At Fair Value as first filed 15.53M EUR.
| Period end | Financial Liabilities At Fair Value | Financial Liabilities At Fair Value as first filed |
|---|---|---|
| 2022-06-30 | 13.55M EUR 6-K · filed 2022-08-05 | |
| 2021-12-31 | 14.68M EUR 20-F · filed 2023-03-23 | |
| 2021-06-30 | 17.49M EUR 6-K · filed 2021-08-04 | |
| 2020-12-31 | 14.68M EUR 20-F · filed 2022-03-24 | 15.53M EUR 6-K · filed 2021-08-04 |
| 2020-06-30 | 27.20M EUR 6-K · filed 2020-08-07 | |
| 2019-12-31 | 15.53M EUR 20-F · filed 2021-03-24 | 24.75M EUR 20-F · filed 2020-03-25 |
| 2019-06-30 | 24.78M EUR 6-K/A · filed 2019-09-05 | |
| 2018-12-31 | 25.19M EUR 20-F · filed 2019-04-05 | |
| 2017-12-31 | 19.58M EUR 20-F · filed 2018-04-06 |